Europe's advanced therapy medicinal products: Chances and challenges

Expert Review of Medical Devices

Volumn 6, Issue 2, 2009, Pages 109-110

  Mertsching, Heike ^a   Walles, Thorsten ^b  

^a FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB   (Germany)

^b Schillerhoehe Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ADVANCED THERAPY MEDICINAL PRODUCT; BIOMEDICAL TECHNOLOGY ASSESSMENT; BIOTECHNOLOGY; EDITORIAL; EUROPE; GENE THERAPY; GOOD MANUFACTURING PRACTICE; HEALTH CARE ACCESS; LAW; MARKETING; MEDICAL INSTRUMENTATION; NANOMEDICINE; PROCESS DEVELOPMENT; PRODUCT DEVELOPMENT; QUALITY CONTROL; REGENERATIVE MEDICINE; SOMATIC CELL THERAPY; STANDARD; TISSUE ENGINEERING; TRADITIONAL MEDICINE; CYTOLOGY; DRUG LEGISLATION; EMBRYONIC STEM CELL; HUMAN; STEM CELL TRANSPLANTATION;

DRUG;

EMBRYONIC STEM CELLS; EUROPE; GENE THERAPY; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 67449108653     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.6.2.109     Document Type: Editorial

References (5)

1. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103, 1204-1219 (2008).
2. Hegewald AA, Ringe J, Sittinger M, Thome C. Regenerative treatment strategies in spinal surgery. Front. Biosci. 13, 1507-1525 (2008).
3. Caplan AI. Why are MSCs therapeutic? New data: new insight. J. Pathol. 217, 318-324 (2009).
4. Brévignon-Dodin L. ATMP in practice: towards a new industry landscape in tissue engineering. J. Comm. Biotechnol. 15, 59-65 (2009).
5. Hughes-Wilson W, Mackay D. European approval system for advanced therapies: good news for patients and innovators alike. Reg. Med. 2, 5-6 (2007).